FABIAN
SANCHIS GOMAR
INVEST CONT DOCTOR ATR.TALENT
Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (10)
2021
-
Does abdominal obesity influence immunological response to SARS-CoV-2 infection?
Expert Review of Endocrinology and Metabolism, Vol. 16, Núm. 6, pp. 271-272
-
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis
Seminars in Thrombosis and Hemostasis, Vol. 47, Núm. 4, pp. 392-399
-
Role of non-coding RNAs as biomarkers of deleterious cardiovascular effects in sepsis
Progress in Cardiovascular Diseases, Vol. 68, pp. 70-77
2020
-
Global epidemiology and future trends of heart failure
AME Medical Journal, Vol. 5
-
Oxidative stress and inflammation in covid-19-associated sepsis: The potential role of anti-oxidant therapy in avoiding disease progression
Antioxidants, Vol. 9, Núm. 10, pp. 1-20
2019
-
Long-term follow-up and treatment in a case of PAFIYAMA syndrome: urgent need for identifying related biomarkers
AME Medical Journal, Vol. 4
-
Routine cardiac troponin assessment after percutaneous coronary intervention: Useful or hype?
Journal of Cardiovascular Medicine, Vol. 20, Núm. 8, pp. 495-499
2018
-
An Overview of Doping in Sports
Nutrition and Enhanced Sports Performance: Muscle Building, Endurance, and Strength (Elsevier), pp. 189-202
-
“Ultra-sensitive” cardiac troponins: Requirements for effective implementatioin clinical practice
Biochemia Medica, Vol. 28, Núm. 3
2017
-
Challenges in the analysis of epigenetic biomarkers in clinical samples
Clinical Chemistry and Laboratory Medicine, Vol. 55, Núm. 10, pp. 1474-1477